AU3057099A - A drug composition containing sodium pravastatin - Google Patents
A drug composition containing sodium pravastatinInfo
- Publication number
- AU3057099A AU3057099A AU30570/99A AU3057099A AU3057099A AU 3057099 A AU3057099 A AU 3057099A AU 30570/99 A AU30570/99 A AU 30570/99A AU 3057099 A AU3057099 A AU 3057099A AU 3057099 A AU3057099 A AU 3057099A
- Authority
- AU
- Australia
- Prior art keywords
- composition containing
- containing sodium
- drug composition
- sodium pravastatin
- pravastatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980011172A KR100281521B1 (ko) | 1998-03-31 | 1998-03-31 | 프라바스타틴나트륨이 함유된 약제 조성물 |
KR9811172 | 1998-03-31 | ||
PCT/KR1999/000157 WO1999049896A1 (en) | 1998-03-31 | 1999-03-31 | A drug composition containing sodium pravastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3057099A true AU3057099A (en) | 1999-10-18 |
Family
ID=19535615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU30570/99A Abandoned AU3057099A (en) | 1998-03-31 | 1999-03-31 | A drug composition containing sodium pravastatin |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1067967A1 (zh) |
JP (1) | JP2003517432A (zh) |
KR (1) | KR100281521B1 (zh) |
CN (1) | CN1298311A (zh) |
AU (1) | AU3057099A (zh) |
CA (1) | CA2326603A1 (zh) |
WO (1) | WO1999049896A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4658306B2 (ja) * | 2000-10-18 | 2011-03-23 | ナガセ医薬品株式会社 | 錠剤用医薬組成物 |
WO2003055991A1 (en) * | 2001-12-21 | 2003-07-10 | Rigshospitalet | Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux |
EP1490029A4 (en) * | 2002-03-22 | 2006-02-22 | Ranbaxy Lab Ltd | DRUG DELIVERY SYSTEM WITH CONTROLLED RELEASE OF PRAVASTATIN |
US20060229277A1 (en) * | 2005-04-08 | 2006-10-12 | Orbus Pharma, Inc. | Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor |
CA2615941A1 (en) * | 2005-08-05 | 2007-02-15 | Orbus Pharma Inc. | Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
US7879821B2 (en) * | 2006-01-26 | 2011-02-01 | University Of Medicine And Dentistry Of New Jersey | Method for modulating inflammatory responses by altering plasma lipid levels |
BG934U1 (bg) * | 2006-12-14 | 2007-11-30 | "Софарма" Ад | Състав за твърда лекарствена форма, съдържащ правастатин |
GB0713707D0 (en) * | 2007-07-13 | 2007-08-22 | Generics Uk Ltd | Stable compositions |
CN101580466B (zh) * | 2008-05-12 | 2012-04-04 | 上海天伟生物制药有限公司 | 一种萘维太定的钠盐的制备方法 |
JP4890657B1 (ja) * | 2011-06-03 | 2012-03-07 | 小野薬品工業株式会社 | リマプロストとβ−シクロデキストリンを含有する錠剤 |
JP2013147488A (ja) * | 2011-12-21 | 2013-08-01 | Taisho Pharmaceutical Co Ltd | 固形製剤 |
JP6088872B2 (ja) * | 2013-03-22 | 2017-03-01 | サラヤ株式会社 | ラクトン型ソホロリピッドの分解が抑制されたソホロリピッド粉末 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3223232C2 (de) * | 1982-06-22 | 1984-04-05 | Wolfgang Dipl.-Phys. Dr.-Ing. 4800 Bielefeld Lindemann | Vorschubeinrichtung an einer mit einem umlaufenden Werkzeug versehenen Maschine, wie Schäl- oder Richtmaschine, für stangenförmiges Material, wie Wellen, Draht, Rohre o.dgl. |
DD232198A1 (de) * | 1984-07-13 | 1986-01-22 | Jenapharm Veb | Verfahren zur herstellung von festen komprimaten |
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
TW224049B (zh) * | 1991-12-31 | 1994-05-21 | Sunkyong Ind Ltd |
-
1998
- 1998-03-31 KR KR1019980011172A patent/KR100281521B1/ko not_active IP Right Cessation
-
1999
- 1999-03-31 CA CA002326603A patent/CA2326603A1/en not_active Abandoned
- 1999-03-31 EP EP99912138A patent/EP1067967A1/en not_active Withdrawn
- 1999-03-31 AU AU30570/99A patent/AU3057099A/en not_active Abandoned
- 1999-03-31 CN CN99805551A patent/CN1298311A/zh active Pending
- 1999-03-31 WO PCT/KR1999/000157 patent/WO1999049896A1/en not_active Application Discontinuation
- 1999-03-31 JP JP2000540858A patent/JP2003517432A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999049896A1 (en) | 1999-10-07 |
CN1298311A (zh) | 2001-06-06 |
KR100281521B1 (ko) | 2001-02-15 |
CA2326603A1 (en) | 1999-10-07 |
JP2003517432A (ja) | 2003-05-27 |
KR19990076302A (ko) | 1999-10-15 |
EP1067967A1 (en) | 2001-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1071301A (en) | Pharmaceutical compounds | |
AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
AU6740298A (en) | Pharmaceutical composition | |
IL139210A (en) | Pharmaceutical composition containing a macrolide compound | |
AU7590096A (en) | Drug composition | |
AU1574900A (en) | Pharmaceutical compositions containing insulin | |
AU4143999A (en) | Oral composition comprising capsules | |
AU1887401A (en) | Medicinal composition | |
AU6904896A (en) | Pharmaceutical compounds | |
AU8107998A (en) | Pharmaceutical compositions | |
AU8591898A (en) | Pharmaceutical compounds | |
AU3057099A (en) | A drug composition containing sodium pravastatin | |
AU6370299A (en) | Pharmaceutical compositions containing tetrahydroisoquinoline compounds | |
AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
AU2531295A (en) | Pharmaceutical composition | |
AU9343098A (en) | Pharmaceutical composition | |
AU1044799A (en) | Pharmaceutical composition containing zafirlukast | |
AU5326298A (en) | Pharmaceutical compositions containing N-sulphonylindoline derivatives | |
AU5722900A (en) | Pharmaceutical compounds | |
AU6480299A (en) | Pharmaceutical compounds | |
AUPP332898A0 (en) | Pharmaceutical composition | |
AU1688099A (en) | Pharmaceutical preparation | |
AU5184599A (en) | Pharmaceutical compounds | |
AU7546096A (en) | Pharmaceutical compounds | |
AU4726299A (en) | Drug dispenser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |